Drug Discovery World

NOVEMBER 13, 2023

Novel/alternative ML-enabled screening technologies for higher POS Following chairperson’s remarks from M Frank Erasmus, PhD, Head, Bioinformatics, Specifica, there will be four presentations and a panel discussion.

Engineering 147

Engineering Science Bioinformatics Vaccine 147

Drug Discovery World

NOVEMBER 8, 2023

The presentations include: Mark Cragg, PhD, Professor of Experimental Cancer Biology, Antibody and Vaccine Group, School of Cancer Sciences, University of Southampton, on: ‘Modulating antibody effector functions in the tumour microenvironment’. The presentations which follow include: Peter Tessier, PhD, Albert M.

Engineering 162

Engineering Protein Expression Therapies Science 162

Drug Discovery World

NOVEMBER 30, 2023

From a product perspective, RedShiftBio had the Aurora protein analyser with them in Lisbon this year. It was presented by Xiaole Shirley Liu, PhD, CEO, GV20 Therapeutics, and titled: ‘AI-based target and antibody discovery from patient tumour profiles’.

Protein Expression 147

Protein Expression Engineering DNA Therapies 147

Codon

AUGUST 10, 2023

Link The PURE system for the cell-free synthesis of membrane proteins , by Kuruma Y. & Link An integrated cell-free metabolic platform for protein production and synthetic biology , by Jewett M.C. & Ueda T. Nature Protocols (2015). Molecular Systems Biology (2008).

DNA 52

DNA Cell Biology Engineering Molecular Biology 52